NVRO Nevro Corp

  1. Stocks
  2. Healthcare
  3. NYSE: NVRO

Price (delayed)

$18.92

Market cap

$685.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.87

Enterprise value

$813.15M

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
The revenue has grown by 7% YoY
The gross profit has grown by 5% YoY
NVRO's quick ratio is down by 14% year-on-year and by 5% since the previous quarter
The equity has contracted by 12% YoY and by 3.1% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.nevro.com
Peers: ISRG TMO OFIX TNDM

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
36.21M
Market cap
$685.01M
Enterprise value
$813.15M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.39
Price to sales (P/S)
1.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.92
Earnings
Revenue
$422.84M
EBIT
-$94.67M
EBITDA
-$83.82M
Free cash flow
-$72.45M
Per share
EPS
-$2.87
Free cash flow per share
-$2
Book value per share
$7.91
Revenue per share
$11.7
TBVPS
$15.54
Balance sheet
Total assets
$561.58M
Total liabilities
$275.92M
Debt
$193.91M
Equity
$285.67M
Working capital
$442.24M
Liquidity
Debt to equity
0.68
Current ratio
6.55
Quick ratio
4.89
Net debt/EBITDA
-1.53
Margins
EBITDA margin
-19.8%
Gross margin
67.1%
Net margin
-24.2%
Operating margin
-25.3%
Efficiency
Return on assets
-17.8%
Return on equity
-34%
Return on invested capital
-15.4%
Return on capital employed
-19.6%
Return on sales
-22.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
2.66%
1 week
12.89%
1 month
15.93%
1 year
-54.57%
YTD
-52.22%
QTD
-1.56%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$422.84M
Gross profit
$283.82M
Operating income
-$106.88M
Net income
-$102.42M
Gross margin
67.1%
Net margin
-24.2%
The revenue has grown by 7% YoY
The gross profit has grown by 5% YoY

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
2.39
P/S
1.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.92
NVRO's P/B is 76% below its 5-year quarterly average of 9.8 and 32% below its last 4 quarters average of 3.5
The equity has contracted by 12% YoY and by 3.1% from the previous quarter
The P/S is 78% lower than the 5-year quarterly average of 7.4 and 38% lower than the last 4 quarters average of 2.6
The revenue has grown by 7% YoY

Efficiency

How efficient is Nevro business performance

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 104% greater than its total liabilities
NVRO's quick ratio is down by 14% year-on-year and by 5% since the previous quarter
NVRO's total assets is down by 7% year-on-year
The debt is 32% smaller than the equity
The equity has contracted by 12% YoY and by 3.1% from the previous quarter
The debt to equity has increased by 11% YoY and by 3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.